New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For APKT;ORCL;SONS;HLF;NUS;BTH;PKT;RMTI;MOBI;PC;RCL;CLX;HUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
October 24, 2014
08:45 EDTRCLRoyal Caribbean sell-off unwarranted, says Stifel
Subscribe for More Information
05:54 EDTHLFStocks with implied volatility movement; NPSP HLF
Subscribe for More Information
October 23, 2014
14:44 EDTRCLRoyal Caribbean has a conference call hosted by UBS
UBS Analyst Farley hosts a conference call with CFO Jason Liberty and Laura Hodges, Investor Relations on October 23 at 3 pm.
08:38 EDTRCLRoyal Caribbean sees FY15 EPS $4.55, consensus $4.60
The company is experiencing strong early booking trends for 2015. Booked load factors and APDs are higher than same time last year and the booking window has extended. Europe sailings are off to a particularly good start, with strong booking trends from North America and from Europe. Caribbean pricing pressure continues through the first quarter, but we expect it to improve thereafter. The company has sufficient visibility into 2015 to say that it is comfortable with the Street consensus of $4.55 per share.
08:37 EDTRCLRoyal Caribbean sees Q4 adjusted EPS 35c-40c, consensus 46c
Subscribe for More Information
08:36 EDTRCLRoyal Caribbean: Trajectory for 2014 continues along path described 3 months ago
Subscribe for More Information
08:35 EDTRCLRoyal Caribbean sees FY14 $3.45, consensus $3.51
Subscribe for More Information
08:35 EDTRCLRoyal Caribbean reports Q3 net yields up 4.2% on constant currency basis
Subscribe for More Information
08:34 EDTRCLRoyal Caribbean: Early bookings for 2915 are robust
Subscribe for More Information
08:34 EDTRCLRoyal Caribbean reports Q3 adjusted EPS $2.20, consensus $2.19
Reports Q3 revenue $2.39B, consensus $2.40B
07:15 EDTSONSSonus sees FY14 EPS 7c, consensus 7c
Subscribe for More Information
07:14 EDTSONSSonus sees Q4 EPS 3c, consensus 3c
Subscribe for More Information
07:13 EDTSONSSonus reports Q3 EPS 1c, consensus 1c
Reports Q3 revenue $73.2M, consensus $71.97M.
October 22, 2014
13:58 EDTHUMHumana hires Goldman to explore sale of urgent care unit, Reuters reports
Humana has hired investment bank Goldman Sachs to advise on a potential sale of its urgent care subsidiary, Concentra, according to Reuters, citing three people familiar with the matter. A deal could value the subsidiary, which Humana acquired less than four years ago, at around $1B, the report noted. Reference Link
12:55 EDTHLFPivotal analyst says Herbalife 'just not a pyramid scheme'
Pivotal Research analyst Tim Ramey said on CNBC that Herbalife "is just not a pyramid scheme."
10:36 EDTORCLOracle downgraded to Neutral from Buy at Tigress Financial
Subscribe for More Information
October 21, 2014
18:33 EDTHLFIcahn reiterates view that high-yield market is a bubble
Says the Fed has given the economy, or the patient, "too much medicine." Says market should not be shorted. Again, says Apple (AAPL) CEO Tim is a "great CEO." Says Apple pay has a great future. Says Ebay (EBAY) is like his past campaign at Motorola. Reiterates view that Ebay should explore Paypal sale right now. Says Dell is on his radar screen. Says Warren Buffet sometimes too easy on companies, should do more on corporate governance. Again, says has never sold a share of Herbalife (HLF). Says Western Europe has "major problems," and continues to be short the Euro. Says energy stocks "getting cheap." Carl Icahn is speaking on Bloomberg TV.
14:34 EDTORCLEarnings Preview: EMC reports after HPQ merger talks said to end
EMC Corporation (EMC) is expected to report third quarter earnings before the bell on Wednesday, October 22, with a conference call scheduled for 8:30 am ET. EMC provides software, hardware and IT services to business customers through its three federated businesses: EMC Information Infrastructure, Pivotal and VMware Virtual Infrastructure, which is represented by EMC’s majority equity stake in VMware (VMW). VMware is expected to report on its own third quarter results after the bell on Tuesday, October 21, with a conference call scheduled for 5:00 pm ET. EXPECTATIONS: For EMC, analysts are looking for earnings per share of 46c on revenue of $6.0B. The consensus range is 44c-49c for EPS and $5.91B-$6.16B for revenue, according to First Call. Along with its last earnings report, EMC raised its FY14 adjusted EPS view to $1.91 from $1.90 and guided to FY14 revenues of $24.58B. Analysts consensus for FY14 EPS and revenue currently stand at $1.91 and $24.55B. For VMware, analysts are looking for earnings per share of 83c on revenue of $1.5B. The consensus range is 81c-85c for EPS and $1.48B-$1.52B for revenue, according to First Call. LAST QUARTER: EMC reported Q2 adjusted EPS of 43c, which matched the consensus expectation. EMC's revenue of $5.9B came in slightly ahead of the $5.83B consensus projection. EMC also accelerated its 2014 share buyback plan, stating that it now expects to repurchase an aggregate of $3B of the company's common stock in 2014. VMware reported Q2 EPS of 81c, versus consensus of 79c, on revenue $1.46B, versus consensus of $1.44B. NEWS: VMware held its "VMWorld 2014" conference from August 24-28, during which the company updated its 2015 guidance. VMware's guidance for revenue growth in the mid teens percentage level and margin expansion of up to one percentage point is positive, RBC Capital analyst Matthew Hedberg wrote in a note to investors on August 26. The same day Cowen analyst Gregg Moskowitz wrote that VMware's FY15 revenue guidance would "likely weigh modestly" on the stock, even though he was not surprised by the outlook. Less than two weeks ago, Elliott Management sent a letter to the board of directors of EMC Corporation detailing its recommendations on the right path forward for EMC, in which Elliott holds a stake. Elliott believes that EMC’s Federation structure obscures enormous value at the company and that the board and management should pursue pathways to recognize this value, including a separation of VMware from Core EMC and/or various M&A opportunities, Elliott wrote. In response, EMC said its directors regularly review and evaluate the company's strategy with a view towards enhancing shareholder value. "Over the past few months, EMC's leadership has met with representatives of Elliott several times and has listened carefully to their ideas, as we do with all of our shareholders," the company said. Last week, HP (HPQ) announced the resumption of its share repurchase program after Reuters reported the company's merger talks with EMC had ended. HP had suspended the buyback program due to "possession of material non-public information." The tech giant said that day that it is "no longer in possession of such information." During September, Re/code reported, citing sources familiar with Oracle's plans, that the company was not interested in acquiring EMC. Meanwhile, Cisco (CSCO) CEO John Chambers also said last month at a Wall Street Journal breakfast that his company is not among the potential merger partners for EMC. Chambers said a deal between the two companies would have been done a "year or two ago" were it to happen, according to Reuters. STREET RESEARCH: On the day after its last earnings report, Brean Capital raised its price target on EMC to $33 from $30, citing the company's aggressive capital return strategy, encouraging core Storage dynamics and potential pent up demand. Tigress Financial, however, downgraded EMC to Buy from Strong Buy, citing valuation. Additionally, VMware estimated that its total available market would reach more than $60B in 2017, versus its estimate last year of a $50B+ total addressable market by 2016, Moskowitz noted. PRICE ACTION: In afternoon trading, EMC shares are up 1% to $27.22, while VMware is fractionally higher at $87.79. Over the last three months, EMC shares have declined almost 4%, while VMware's stock is down about 5.5% in that same time frame.
06:40 EDTORCLForrester: Adobe becomes marketing cloud leader, VentureBeat reports
Subscribe for More Information
October 20, 2014
12:39 EDTPKTProcera Networks activist calls for board to evaluate strategic alternatives
Ronald Chez of Merriman Capital sent an open letter to the board of Procera Networks criticizing their lack of execution and failure to deliver on their strategy. Chez said, "I believe it is essential, and consistent with the board's fiduciary duties to Procera shareholders, that the board evaluate all strategic alternatives, including the retention of an investment bank to help guide the process. I have spoken to several shareholders and investment bankers. I intend to actively pursue further discussions with additional shareholders and interested parties. At the earliest possible convenience, I would also like to meet with the board, to discuss the immediate need to change direction." Shares of Procera are up 5.5% to $7.00 following the letter.
12:09 EDTORCLIBM hits 52 week low after earnings miss, 2015 profit target dropped
Subscribe for More Information
11:13 EDTNUSNu Skin volatility elevated
Nu Skin October weekly call option implied volatility is at 95, November is at 73, December is at 72; compared to its 26-week average of 48 according to Track Data, suggesting decreasing price movement.
11:00 EDTHLFHerbalife volatility increases
Subscribe for More Information
08:48 EDTHLFHerbalife initiated with a Buy at Pivotal Research
Subscribe for More Information
08:30 EDTNUSNu Skin initiated with a Buy at Pivotal Research
Target $75.
05:54 EDTHLFStocks with implied volatility movement; HLD SD
Stocks with implied volatility movement; Herbalife (HLF) 109, SandRidge Energy (SD) 97 according to iVolatility.
October 17, 2014
15:15 EDTRMTIRockwell Medical volatility elevated
Rockwell Medical November call option implied volatility is at 164, January is at 121, February is at 122; compared to its 26-week average of 76 according to Track Data, suggesting large price movement into a PDUFA Date for Triferic on January 24, 2015.
October 16, 2014
15:36 EDTRCLRoyal Caribbean volatility elevated on wide price movement
Subscribe for More Information
October 15, 2014
16:37 EDTNUSOn The Fly: Closing Wrap
The market opened sharply lower amid sliding oil prices, worse than expected economic data, and the potential for a major M&A deal to fall apart due to tax inversion rule changes. The Dow fell more than 350 points within the first 30 minutes of trading, but then bounced back to move above its opening level. The volatility did not end there, however, as the market swung several more times during the session. The S&P 500's drop wiped out its gains for the year at one point, but a late day rally significantly cut the losses for the major averages. ECONOMIC EVENTS: In the U.S., retail sales, which were expected to be down 0.1% in September, actually fell 0.3% in the month and slipped 0.2% excluding autos. The Producer Price Index for final demand decreased a seasonally adjusted 0.1% in September from the prior month, marking the first decline in the measure in over a year. The core PPI reading, which excludes food and energy, was unchanged, versus expectations for a 0.1% rise. New York's Empire State manufacturing index fell 21.4 points to 6.2 in October, severely missing the expectation for a narrower pullback to a reading of 20. Business inventories rose 0.2% in August, versus expectations for an increase of 0.4%. In China, the consumer price index climbed 1.6% in September from a year earlier, which was below the consensus projection for 1.7% inflation and down from 2% inflation in August. China's PPI plunged 1.8% year-over-year in September, which was more than the 1.6% slide expected and an acceleration of the 1.2% year-on-year decline in August. COMPANY NEWS: Shares of Shire (SHPG) plunged $74.08, or 30.29%, to $170.49 after AbbVie's (ABBV) board last night stated that it was reconsidering its recommendation that the company's shareholders back a takeover of Irish drugmaker in light of the potential impact of tax rule changes on the deal. During the day, Bloomberg reported that people familiar with the matter say AbbVie is close to abandoning its $51B takeover bid, while Shire announced that it has agreed to waive the requirement for three business days' notice for AbbVie's board to meet to consider its offer. In contrast, AbbVie ended the session up 50c, or 0.92%, at $54.63... Wal-Mart (WMT) held its annual meeting, during which it lowered its fiscal year 2015 net sales growth forecast to 2%-3%, citing a tougher sales environment than it anticipated a year ago. The company indicated in February that it expected net sales growth to be at the low end of its guidance provided last October of 3%-5%. The world's largest retailer also cut its planned retail square foot growth expectations, due to a moderation of large format store growth and accelerated e-commerce investments. Following the outlook revisions, Wal-Mart closed down $2.78, or 3.57%, to $75.20. MAJOR MOVERS: Among the notable gainers was Penford Corporation (PENX), which jumped $7.60, or 69.15%, to $18.59 after the company agreed to be acquired by Ingredion (INGR) for $340M, or $19.00 in cash per share. Also higher was Southwestern Energy (SWN), which rose $2.59, or 7.82%, to $35.69 after it was among a number of oil and gas exploration and production names upgraded by analysts at Bank of America Merrill Lynch. Among the noteworthy losers was Nu Skin (NUS), which dropped $4.47, or 9.13%, to $44.50 after the company disclosed new debt arrangements that come with certain restrictions, including restrictions on the payment of dividends. Also lower were shares of Covidien (COV), which fell $6.50, or 7.04%, to $85.86 in the wake of the news for Shire and AbbVie, which investors may have read as jeopardizing Covidien's deal to be bought by Medtronic (MDT). Note that on October 3 Medtronic announced that it intends to use approximately $16B in external financing to complete the acquisition of Covidien and said the strategic benefits of the transaction "remain compelling" despite the additional expense of the new financing. INDEXES: The Dow dropped 173.45, or 1.06%, to 16,141.74, the Nasdaq slipped 11.85, or 0.28%, to 4,215.32, and the S&P 500 fell 15.21, or 0.81%, to 1,862.49.
11:27 EDTNUSNu Skin falls after announcing debt deal, related restrictions
Subscribe for More Information
11:23 EDTNUSNu Skin not restricted from making dividend payments, says Deutsche Bank
Subscribe for More Information
11:11 EDTNUSNu Skin shares defended at Deutsche Bank
Subscribe for More Information
October 13, 2014
09:01 EDTHLFHerbalife moving distributor websites to central control, NY Post reports
Subscribe for More Information
07:39 EDTHUMPharmaceutical Care Management Association to hold annual meeting
Subscribe for More Information
October 10, 2014
16:22 EDTPKTOn The Fly: Closing Wrap
Stocks on Wall Street had a bit of a see-saw trading day, but ended the session in the red once again. The Nasdaq took the brunt of the losses, falling over 2%, while the Dow's slide erased its gains for the year. ECONOMIC EVENTS: In the U.S., the import price index fell 0.5% in September, versus expectations for a 0.7% decline. Oil slumped to a four-year low during the session, as brent crude touched $88.11 intra-day, its lowest level since December 2010. COMPANY NEWS: The semiconductor sector was weak across the board after one of the companies in the space, Microchip Technology (MCHP), warned that it believes the sector has entered a correction. Microchip President and CEO Steve Sanghi claimed his company often sees the turn of the semiconductor industry ahead of others, noting that it does business with over 80,000 customers and that it built a significant amount of inventory in the distribution channel in the September quarter. Sanghi stated, "We believe that another industry correction has begun and that this correction will be seen more broadly across the industry in the near future.” Microchip, which also pre-announced weaker than expected second quarter revenue, dropped $5.58, or 12.26%, to $39.96. Intel (INTC) fell $1.71, or 5.09%, to $31.91, Avago (AVGO) declined $9.24, or 11.46%, to $71.36, Texas Instruments (TXN) slipped $3.28, or 7.13%, to $42.74 and Micron (MU) dropped $2.71, or 8.86%, to $27.93. MAJOR MOVERS: Among the notable gainers was Exact Sciences (EXAS), which rallied $6.48, or 35.76%, to $24.60 after the company announced last night that the Centers for Medicare & Medicaid Services, or CMS, had agreed to cover the company's colorectal cancer and pre-cancer test through Medicare. Also higher was Dave & Buster (PLAY), which gained $1.28 to $17.28 after commencing trading on the Nasdaq following its initial public offering. Among the noteworthy losers was Procera Networks (PKT), which was downgraded by at least four research firms and plunged $2.85, or 33.33%, to $5.70 after the company warned its Q3 revenue will miss expectations. Also lower were shares of Caesars (CZR), which dropped $1.92, or 17.36%, to $9.14 after disclosing in a regulatory filing that its Chief Accounting Officer resigned to accept a position with another company. INDEXES: The Dow fell 115.15, or 0.69%, to 16,544.10, the Nasdaq plunged 102.10, or 2.33%, to 4,276.24, and the S&P 500 dropped 22.08, or 1.15%, to 1,906.13.
13:08 EDTPKTOn The Fly: Midday Wrap
Stocks on Wall Street opened in negative territory and saw several swings throughout the morning. Near midday the averages were mixed, with the Dow a bit higher and the Nasdaq weighed down by weakness across the semiconductor sector. ECONOMIC EVENTS: In the U.S., the import price index fell 0.5% in September, versus expectations for a 0.7% decline. COMPANY NEWS: Shares of a number of semiconductor makers, including industry giant Intel (INTC), were sharply lower after one of the companies in the space, Microchip Technology (MCHP), warned that it believes the sector has entered a correction. Microchip President and CEO Steve Sanghi claimed his company often sees the turn of the semiconductor industry ahead of others, noting that it does business with over 80,000 customers and that it built a significant amount of inventory in the distribution channel in the September quarter. Sanghi stated, "We believe that another industry correction has begun and that this correction will be seen more broadly across the industry in the near future.” Near noon, Microchip dropped 11%, Intel fell almost 4%, Texas Instruments (TXN) slipped over 6%, Micron (MU) dropped 6% and Fairchild (FCS) declined 12%. MAJOR MOVERS: Among the notable gainers was Exact Sciences (EXAS), which rallied 35% after the company announced last night that the Centers for Medicare & Medicaid Services, or CMS, had agreed to cover the company's colorectal cancer and pre-cancer test through Medicare. Among the noteworthy losers were a number of companies that, similarly to Microchip, warned that their quarterly results will likely miss expectations, including Procera Networks (PKT), which plunged 34%, Manitowoc (MTW), which fell 9%, and Sizmek (SZMK), which dropped 21%. INDEXES: Near midday, the Dow was up 38.02, or 0.23%, to 16,697.27, the Nasdaq was down 35.89, or 0.82%, to 4,342.45, and the S&P 500 was up 0.42, or 0.02%, to 1,928.63.
12:11 EDTHLFOptions with increasing implied volatility
Subscribe for More Information
11:27 EDTNUSPrescott General Patrners reports 4.3% passive stake in Nu Skin
Subscribe for More Information
10:55 EDTHLFHerbalife volatility increases
Subscribe for More Information
10:01 EDTPKTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:00 EDTPKTOn The Fly: Pre-market Movers
Subscribe for More Information
06:00 EDTPKTProcera Networks downgraded to Hold from Buy at Needham
Subscribe for More Information
05:58 EDTPKTProcera Networks downgraded to Hold from Buy at Stifel
Subscribe for More Information
05:58 EDTPKTProcera Networks downgraded to Neutral from Buy at Sterne Agee
Subscribe for More Information
05:52 EDTPKTProcera Networks downgraded to Market Perform from Outperform at William Blair
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use